AEye Reports Fourth Quarter and Full Year 2021 Results
AEye, Inc. (Nasdaq: LIDR) reported a strong performance for 2021, exceeding Wall Street revenue expectations with $3 million in annual revenue. Key milestones included advancements in productization and partnerships with companies like Continental and TuSimple. The company transitioned to manufacturing with Continental for automotive applications and established industry performance standards for lidar technology. Despite a GAAP net loss of $65 million, AEye ended 2021 with $164 million in cash, positioning itself for growth in 2022, targeting revenues of $4 to $6 million.
- Exceeding Wall Street revenue expectations with $3 million in total revenue for 2021.
- Achieved significant advancements in productization and partnerships, setting the foundation for growth.
- Established new industry performance standards for lidar technology.
- Ended 2021 with $164 million in cash and is debt-free.
- GAAP net loss of $(65) million for 2021, equating to $(0.60) per share.
- Projected non-GAAP net loss of approximately $(100) million for 2022.
Achieved Significant Progress Against Strategic Growth Initiatives
Full-year Revenue Performance Exceeded Wall Street Expectations
Strategic Milestones Achieved 2021
-
Financial
-
AEye made its debut by listing on Nasdaq (LIDR), raising more than , net of fees, to fund product development, increase scale, and support AEye’s growing customer base. In December, the Company announced a$200 million Common Stock Purchase Agreement.$125 million
-
-
Product
-
AEye established new lidar industry performance standards for range, rate, and resolution in performance specification tests monitored, validated, and published byVSI Labs , one of the nation’s leading independent evaluators of active safety and automated vehicle technologies. -
AEye validated superior weather performance, as documented in the journal Atmosphere. -
In alignment with
AEye CEOBlair LaCorte's article in Forbes on software-defined vehicles,AEye is enabling foundational over-the-air (OTA) update capabilities across all products.
-
-
Manufacturing
-
ADAS:
AEye transitioned initial production of automotive B-samples ofAEye -based long-range lidar sensors to a Continental manufacturing line. The Continental HRL131 is on-track for large-scale series production in 2024. The HRL131 will be manufactured, sold, and supported, under Continental’s brand, to its installed base of 25 ADAS customers/OEMs. -
Industrial:
AEye transitioned manufacturing of AEye’s 4Sight M sensor for industrial and mobility applications from AEye’sAdvanced Development Center inDublin, CA to Sanmina, AEye’s lead contract manufacturing partner.
-
ADAS:
-
Customers and Partners - Continental announced the integration of AEye’s lidar technology into its full-stack (cameras, radar, lidar, and ECU) automotive-grade system for Level 2+ automated and autonomous driving applications – allowing Continental to sell a standalone high-performance long-range lidar sensor or as part of a complete ADAS system.
-
AEye announced a partnership with TuSimple to deploy AEye’s long-range, high-performance lidar for autonomous trucking applications. -
AEye announced integration of its adaptive lidar with the Nvidia DRIVE Platform for autonomous vehicles. -
AEye launched its adaptive lidar solutions for Intelligent Transportation Systems at theITS World Congress inHamburg in October. -
AEye , as previously announced, is working with leaders in other industrial markets such as Komatsu (construction) and Hitachi (rail).
-
Governance
-
A new board of directors was elected, bringing to
AEye extensive public governance, legal, and financial management experience, as well as deep domain expertise in the automotive, trucking, aerospace, and defense markets.
-
A new board of directors was elected, bringing to
- Scaling the Company
-
Innovation
-
AEye filed its 100th patent for groundbreaking concepts that meaningfully strengthen AEye’s IP protection and competitive position. -
AEye was named a 2022 Innovation Award Winner by bothFast Company and the Consumer Electronics Show (CES).
-
Q4 2021 Financials
Full Year 2021 Financials
Adjusted EBITDA is a non-GAAP financial measure. Refer to “Non-GAAP Financial Measures” for a discussion of Adjusted EBITDA and the financial tables below for reconciliations of Adjusted EBITDA to GAAP net loss, the most directly comparable GAAP financial measure.
The Company ended 2021 with
Looking to 2022
The Company is targeting
Conference Call and Webcast Details
The webcast and accompanying slides will be accessible via the Company’s website at https://investors.aeye.ai/.
The call is also accessible via telephone through the following details:
Dial in Information:
-
US/
CANADA Participant Toll-Free Dial-In Number: 866-652-5200 -
US/
CANADA Participant International Dial-In Number: 412-317-6060
About
AEye’s software-defined lidar enables advanced driver-assistance, vehicle autonomy, and industrial applications that save lives and propel the future of transportation and mobility. The company's 4Sight™ Intelligent Sensing Platform uses adaptive lidar to focus on what matters most: enabling faster, more accurate and reliable perception for dynamic applications ranging from autonomous driving to intelligent infrastructure, which require precise measurement imaging to ensure safety and performance. The company was founded in 2013 and is based in the
Non-GAAP Financial Measures
The non-GAAP measures provided in this press release should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with generally accepted accounting principles (GAAP) in
This presentation includes non-GAAP financial measures, including:
- Non-GAAP net loss which is defined as GAAP net loss plus stock-based compensation, plus expenses related to the registration statement on Form S-1 on behalf of selling stockholders, plus common stock purchase agreement costs, less change in fair value of embedded derivative and warrant liabilities, less the gain on our PPP loan forgiveness; and
- Adjusted EBITDA which is defined as non-GAAP net loss plus amortization and depreciation expense, plus interest expense and other, less interest income and other.
Forward-Looking Statements
Certain statements included in this press release that are not historical facts are forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as “believe,” “continue,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “predict,” “plan,” “may,” “should,” “will,” “would,” “potential,” “seem,” “seek,” “outlook,” and similar expressions that predict or indicate future events or trends, or that are not statements of historical matters. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These statements are based on various assumptions, whether or not identified in this press release. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are very difficult or impossible to predict and will differ from the assumptions. Many actual events and circumstances are beyond the control of
Readers are cautioned not to put undue reliance on forward-looking statements;
|
||||||||
As of |
||||||||
2021 |
2020 |
|||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 14,183 |
$ | 15,275 |
||||
Marketable securities | 149,824 |
- |
||||||
Accounts receivable, net | 4,222 |
156 |
||||||
Inventories, net | 4,085 |
2,655 |
||||||
Prepaid and other current assets | 5,051 |
1,396 |
||||||
Total current assets | 177,365 |
19,482 |
||||||
Property and equipment, net | 5,129 |
4,865 |
||||||
Restricted cash | 2,150 |
1,223 |
||||||
Other noncurrent assets | 1,509 |
315 |
||||||
Total assets | $ | 186,153 |
$ | 25,885 |
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||
Current Liabilities: | ||||||||
Accounts payable | $ | 2,542 |
$ | 1,807 |
||||
Accrued expenses and other current liabilities | 8,739 |
3,356 |
||||||
Contract liabilities | 2,287 |
660 |
||||||
Convertible notes | - |
29,079 |
||||||
Borrowing - net of debt issuance costs, current | - |
2,693 |
||||||
Total current liabilities | 13,568 |
37,595 |
||||||
Deferred rent, noncurrent | 3,032 |
3,631 |
||||||
Borrowings - net of debt issuance costs, noncurrent | - |
2,884 |
||||||
Other noncurrent liabilities | 786 |
- |
||||||
Total liabilities | 17,386 |
44,110 |
||||||
Stockholders’ Equity (Deficit): | ||||||||
Preferred stock | - |
- |
||||||
Common stock | 16 |
10 |
||||||
Additional paid-in capital | 320,937 |
68,549 |
||||||
Accumulated other comprehensive loss | (391) |
- |
||||||
Accumulated deficit | (151,795) |
(86,784) |
||||||
Total stockholders’ equity (deficit) | 168,767 |
(18,225) |
||||||
Total liabilities and stockholders’ equity (deficit) | $ | 186,153 |
$ | 25,885 |
||||
|
||||||||||||
Three months ended |
Year ended |
|||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||
Revenue: | ||||||||||||
Prototype sales | $ | 416 |
$ | 215 |
$ | 1,004 |
$ | 365 |
||||
Development contracts | 1,388 |
64 |
2,003 |
1,214 |
||||||||
Total revenues | 1,804 |
279 |
3,007 |
1,579 |
||||||||
Cost of revenue | 2,100 |
344 |
3,637 |
808 |
||||||||
Gross profit (loss) | (296) |
(65) |
(630) |
771 |
||||||||
Operating Expenses: | ||||||||||||
Research and development | 7,513 |
5,923 |
26,543 |
17,130 |
||||||||
Sales and marketing | 4,059 |
798 |
10,548 |
3,408 |
||||||||
General and administrative | 11,668 |
1,853 |
25,514 |
6,715 |
||||||||
Total operating expenses | 23,240 |
8,574 |
62,605 |
27,253 |
||||||||
Loss from operations | (23,536) |
(8,639) |
(63,235) |
(26,482) |
||||||||
Other income (expense), net: | ||||||||||||
Change in fair value of embedded derivative liability and warrant liabilities | 1 |
126 |
223 |
1,410 |
||||||||
Gain on PPP loan forgiveness | - |
- |
2,297 |
- |
||||||||
Interest income and other | 487 |
4 |
561 |
23 |
||||||||
Interest expense and other | (1,986) |
(547) |
(4,857) |
(1,502) |
||||||||
Total other income (expense), net | (1,498) |
(417) |
(1,776) |
(69) |
||||||||
Provision for income tax expense | - |
- |
- |
- |
||||||||
Net loss | $ | (25,034) |
$ | (9,056) |
$ | (65,011) |
$ | (26,551) |
||||
Per Share Data | ||||||||||||
Net loss per common share (basic and diluted) | $ | (0.16) |
$ | (0.09) |
$ | (0.60) |
$ | (0.26) |
||||
Weighted average common shares outstanding (basic and diluted) | 154,616,998 |
99,854,569 |
109,055,894 |
102,803,202 |
||||||||
|
||||||||
Year ended |
||||||||
2021 |
2020 |
|||||||
Cash flow from operating activities: | ||||||||
Net loss | $ | (65,011) |
$ | (26,551) |
||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | 1,014 |
922 |
||||||
Noncash common stock purchase agreement costs | 1,583 |
- |
||||||
Inventory write-downs | 1,203 |
72 |
||||||
Change in fair value of embedded derivative liability and warrant liabilities | (223) |
(1,410) |
||||||
Noncash gain on PPP loan forgiveness | (2,297) |
- |
||||||
Stock-based compensation | 10,018 |
1,952 |
||||||
Amortization of debt issuance costs | 725 |
97 |
||||||
Amortization of debt discount | 752 |
830 |
||||||
Amortization of premiums on marketable securities, net of change in accrued interest | 310 |
- |
||||||
Other | 287 |
68 |
||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | (4,066) |
(13) |
||||||
Inventories, net | (2,633) |
(309) |
||||||
Prepaid and other current assets | (3,655) |
3,811 |
||||||
Other noncurrent assets | (1,483) |
(193) |
||||||
Accounts payable | 557 |
484 |
||||||
Accrued expenses and other current liabilities | 5,496 |
1,377 |
||||||
Deferred rent | (538) |
(496) |
||||||
Contract liabilities | 2,258 |
(290) |
||||||
Net cash used in operating activities | (55,703) |
(19,689) |
||||||
Cash flows from investing activities: | ||||||||
Purchase of property and equipment | (1,021) |
(4,036) |
||||||
Purchase of available-for-sale debt securities | (150,525) |
- |
||||||
Net cash used in investing activities | (151,546) |
(4,036) |
||||||
Cash flows from financing activities: | ||||||||
Proceeds from the exercise of stock options | 150 |
663 |
||||||
Proceeds from Business Combination and PIPE financing | 256,811 |
- |
||||||
Transaction costs related to Business Combination and PIPE financing | (52,372) |
- |
||||||
Proceeds from the issuance of convertible notes | 8,045 |
29,990 |
||||||
Proceeds from bank loans | 10,000 |
2,270 |
||||||
Principal payments on bank loans | (13,333) |
(667) |
||||||
Payments of debt issuance costs | (717) |
(238) |
||||||
Repurchase of stock options | (1,500) |
- |
||||||
Net cash provided by financing activities | 207,084 |
32,018 |
||||||
Net increase (decrease) in cash and cash equivalents and restricted cash | (165) |
8,293 |
||||||
Cash, cash equivalents and restricted cash at beginning of period | 16,498 |
8,205 |
||||||
Cash, cash equivalents and restricted cash at end of period | $ | 16,333 |
$ | 16,498 |
||||
|
||||||||||||
Three months ended |
Year ended |
|||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||
GAAP net loss | $ | (25,034) |
$ | (9,056) |
$ | (65,011) |
$ | (26,551) |
||||
Non-GAAP adjustments: | ||||||||||||
Stock-based compensation | 3,496 |
1,137 |
10,018 |
1,952 |
||||||||
Expenses related to registration statement on Form S-1 on behalf of selling stockholders | - |
- |
2,198 |
- |
||||||||
Common stock purchase agreement costs | 1,583 |
- |
1,583 |
- |
||||||||
Change in fair value of embedded derivative and warrant liabilities | (1) |
(126) |
(223) |
(1,410) |
||||||||
Gain on PPP loan forgiveness | - |
- |
(2,297) |
- |
||||||||
Non-GAAP net loss | $ | (19,956) |
$ | (8,045) |
$ | (53,732) |
$ | (26,009) |
||||
Depreciation and amortization expense | 245 |
243 |
1,014 |
922 |
||||||||
Interest income and other | (487) |
(4) |
(561) |
(23) |
||||||||
Interest expense and other | 403 |
547 |
3,274 |
1,502 |
||||||||
Adjusted EBITDA | $ | (19,795) |
$ | (7,259) |
$ | (50,005) |
$ | (23,608) |
||||
GAAP net loss per share attributable to common stockholders: | ||||||||||||
Basic and diluted | $ | (0.16) |
$ | (0.09) |
$ | (0.60) |
$ | (0.26) |
||||
Non-GAAP net loss per share attributable to common stockholders: | ||||||||||||
Basic and diluted | $ | (0.13) |
$ | (0.08) |
$ | (0.49) |
$ | (0.25) |
||||
Shares used in computing GAAP net loss per share attributable to common stockholders: | ||||||||||||
Basic and diluted | 154,616,998 |
99,854,569 |
109,055,894 |
102,803,202 |
||||||||
Shares used in computing Non-GAAP net loss per share attributable to common stockholders: | ||||||||||||
Basic and diluted | 154,616,998 |
99,854,569 |
109,055,894 |
102,803,202 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220328005202/en/
Media:
jennifer@aeye.ai
925-400-4366
AEye@landispr.com
415-717-9133
Investors:
cmontevirgen@aeye.ai
925-400-4366
AEye@lambert.com
212-971-9718
Source:
FAQ
What were AEye's full-year revenue results for 2021?
What is AEye's stock symbol?
What were AEye's financial losses in 2021?
What revenue does AEye expect in 2022?